Orrstown Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $234K | Sell |
9,731
-42
| -0.4% | -$1.1K | 0.03% | 116 |
|
|
2026
Q1 | $274K | Hold |
9,773
| – | – | 0.05% | 110 |
|
|
2025
Q4 | $243K | Buy |
9,773
+1,000
| +11% | +$25.2K | 0.04% | 113 |
|
|
2025
Q3 | $224K | Sell |
8,773
-561
| -6% | -$13.8K | 0.04% | 122 |
|
|
2025
Q2 | $226K | Sell |
9,334
-927
| -9% | -$21.6K | 0.05% | 133 |
|
|
2025
Q1 | $260K | Sell |
10,261
-3,065
| -23% | -$80.2K | 0.06% | 112 |
|
|
2024
Q4 | $354K | Sell |
13,326
-1,414
| -10% | -$38.4K | 0.09% | 108 |
|
|
2024
Q3 | $427K | Buy |
+14,740
| New | +$430K | 0.13% | 101 |
|
|
2019
Q4 | – | Sell |
-20,598
| Closed | -$695K | – | 181 |
|
|
2019
Q3 | $695K | Buy |
20,598
+143
| +0.7% | +$5.2K | 0.93% | 54 |
|
|
2019
Q2 | $840K | Buy |
20,455
+18,154
| +789% | +$721K | 1.15% | 37 |
|
|
2019
Q1 | $93K | Buy |
2,301
+1,089
| +90% | +$43.6K | 0.13% | 106 |
|
|
2018
Q4 | $50K | Sell |
1,212
-422
| -26% | -$17.5K | 0.08% | 115 |
|
|
2018
Q3 | $68K | Sell |
1,634
-395
| -19% | -$15.2K | 0.09% | 111 |
|
|
2018
Q2 | $70K | Hold |
2,029
| – | – | 0.09% | 125 |
|
|
2018
Q1 | $68K | Buy |
2,029
+527
| +35% | +$18.1K | 0.08% | 130 |
|
|
2017
Q4 | $52K | Buy |
1,502
+527
| +54% | +$18K | 0.06% | 145 |
|
|
2017
Q3 | $33K | Hold |
975
| – | – | 0.04% | 175 |
|
|
2017
Q2 | $31K | Sell |
975
-2,477
| -72% | -$78.1K | 0.03% | 169 |
|
|
2017
Q1 | $112K | Buy |
3,452
+645
| +23% | +$20.3K | 0.11% | 104 |
|
|
2016
Q4 | $86K | Hold |
2,807
| – | – | 0.09% | 107 |
|
|
2016
Q3 | $90K | Hold |
2,807
| – | – | 0.09% | 103 |
|
|
2016
Q2 | $94K | Buy |
2,807
+158
| +6% | +$5.04K | 0.1% | 97 |
|
|
2016
Q1 | $74K | Sell |
2,649
-566
| -18% | -$16.2K | 0.08% | 100 |
|
|
2015
Q4 | $98K | Sell |
3,215
-418
| -12% | -$13.2K | 0.11% | 95 |
|
|
2015
Q3 | $108K | Sell |
3,633
-1,581
| -30% | -$50.7K | 0.13% | 90 |
|
|
2015
Q2 | $166K | Buy |
5,214
+418
| +9% | +$13.6K | 0.18% | 86 |
|
|
2015
Q1 | $158K | Hold |
4,796
| – | – | 0.17% | 85 |
|
|
2014
Q4 | $142K | Hold |
4,796
| – | – | 0.15% | 86 |
|
|
2014
Q3 | $134K | Hold |
4,796
| – | – | 0.15% | 90 |
|
|
2014
Q2 | $135K | Sell |
4,796
-632
| -12% | -$18K | 0.14% | 80 |
|
|
2014
Q1 | $165K | Hold |
5,428
| – | – | 0.18% | 81 |
|
|
2013
Q4 | $158K | Hold |
5,428
| – | – | 0.16% | 83 |
|
|
2013
Q3 | $148K | Hold |
5,428
| – | – | 0.17% | 87 |
|
|
2013
Q2 | $144K | Buy |
+5,428
| New | +$150K | 0.21% | 73 |
|
Other funds holding PFE
AIM
SLAM
CWP
Orrstown Financial Services's PFE Position: Q2 2026 in Review
Orrstown Financial Services reduced its Pfizer (PFE) stake by 0.43% in Q2 2026, selling an estimated $1.1K and leaving 9,731 shares worth $234K. The position accounts for 0.03% of the portfolio, ranked #116.
Orrstown Financial Services first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. The position peaked at $840K in Q2 2019. 1,140 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Orrstown Financial Services held 9,731 shares of Pfizer worth $234K as of Q2 2026.
- Orrstown Financial Services sold 42 Pfizer shares in Q2 2026, an estimated $1.1K.
- Pfizer made up 0.03% of Orrstown Financial Services's portfolio in Q2 2026, its #116 holding.
- Orrstown Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- Orrstown Financial Services's Pfizer position peaked at $840K in Q2 2019.
- 1,140 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Orrstown Financial Services's 13F filing for Q2 2026, filed 10 Jul 2026.